FAQ/Help |
Calendar |
Search |
Today's Posts |
![]() |
#6 | ||
|
|||
Junior Member
|
Probably simply a matter of semantics, but, if the disease progression is slowing, then sx manifestation will also be slowing/changing for the better. Mind showing me the source for your statement that C wasn't developed to impact sx?
|
||
![]() |
![]() |
|
|
![]() |
||||
Thread | Forum | |||
CytRx to Proceed with Arimoclomol Maximum Dose Study | ALS | |||
More Good News On Copaxone | Multiple Sclerosis | |||
Double dose Copaxone more effective than single dose | Multiple Sclerosis | |||
Combo of copaxone with IVSM offers early/persistent effects on MRI | Multiple Sclerosis |